腹膜外单孔机器人辅助根治性前列腺切除术:初步经验与技术描述
本文描述了腹膜外单孔(SP)机器人辅助根治性前列腺切除术(RARP)的技术,并报告了连续10例局限性前列腺癌患者的初步临床经验。所有手术均由单一术者完成,无中转开放或术中并发症,中位手术时间197.5分钟,估计出血量50-400 mL,6例患者手术当日出院。作者认为该技术可行且安全,但需进一步研究验证其优势。
要点
- 腹膜外单孔机器人辅助根治性前列腺切除术在10例局限性前列腺癌患者中可行且安全。
- 中位手术时间197.5分钟,估计出血量50-400 mL,无中转开放或术中并发症。
- 6例患者手术当日出院,术后留置Foley导尿管中位时间8天。
核心结论
- 腹膜外单孔机器人辅助根治性前列腺切除术是治疗局限性前列腺癌可行且安全的手术选择。
- 作者早期经验发现小单切口、无额外端口、无Trendelenburg体位、术后疼痛及阿片类药物使用少、当日出院等有前景的结果和可能优势。
- 作者指出需进一步研究验证这些优势。
研究设计与样本
- 单术者前瞻性病例系列,连续纳入10例局限性前列腺癌患者,接受腹膜外单孔机器人辅助根治性前列腺切除术。
- 使用da Vinci SP®手术系统,排除既往经脐下正中切口手术史、前列腺体积>100 g或术前证据提示前列腺外病变者。
- 所有手术由单一具有>3000例机器人手术经验的术者完成。
主要发现
- 患者年龄48-70岁,术前前列腺特异性抗原(PSA)平均水平为9 ng/mL。
- 无中转开放或术中并发症记录。
- 中位(四分位距)手术时间为197.5(185.5-229.7)分钟。
- 估计出血量范围为50-400 mL。
- 6例患者于手术当日出院,术后Foley导尿管留置中位时间为8天。
局限性
- 作者指出需进一步研究以验证所观察到的优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe our technique of extraperitoneal single-port (SP) robot-assisted radical prostatectomy (RARP) and present our clinical experience with the first 10 cases. PATIENTS AND METHODS: In all, 10 consecutive patients diagnosed with localised prostate cancer underwent extraperitoneal SP-RARP using the da Vinci SP® Surgical System (Intuitive Surgical, Sunnyvale, CA, USA). Exclusion criteria included previous surgery through an infra-umbilical midline incision, prostate size >100 g, or preoperative evidence of extraprostatic disease. All surgeries were performed by a single surgeon with previous experience of >3000 cases in robotic surgery. Demographics and perioperative information were collected including: operative time, estimated blood loss (EBL), complications, length of stay, and days with Foley catheter. The extraperitoneal SP-RARP is performed as follows. Firstly, a 3-cm incision ~2 cm below the umbilicus is made. Dissection of the extraperitoneal space is achieved using a kidney shaped Spacemaker™ balloon (Covidien, Dublin, Ireland), placed through the infra-umbilical incision caudally reaching the retropubic space. Thereafter, the balloon is deployed; the space is created and verified under direct vision with a laparoscopic endoscope. A GelPOINT® mini advanced access platform (Applied Medical, Rancho Santa Margarita, CA, USA) is inserted and a dedicated 25-mm multichannel port is placed with a 12-mm accessory laparoscopic port through the gel-seal cap into the same incision. The da Vinci SP surgical platform robot is docked with the patient in a supine position. RARP is performed replicating the technique previously described for multi-arm platforms or transperitoneal SP-RARP. No drain and no additional assistant ports were utilised. RESULTS: The patient's ages ranged between 48 and 70 years, and the mean preoperative prostate-specific antigen (PSA) level was 9 ng/mL. No conversions or intraoperative complications were recorded. The median (interquartile range) operative time was 197.5 (185.5-229.7) min. EBL ranged between 50 and 400 mL, six patients were discharged on the same day as the surgery and the median time with a Foley catheter after surgery was 8 days. CONCLUSIONS: Extraperitoneal SP-RARP is a feasible and safe surgical option to treat localised prostate cancer. In our early experience, promising results and possible advantages were found such as: a small single incision, no additional ports, no Trendelenburg positioning, minimal postoperative pain and use of opioids, and same day discharge. Further investigations need to be done to validate these advantages.
引用
- Kaouk J, Valero R, Sawczyn G, et al. Extraperitoneal single-port robot-assisted radical prostatectomy: initial experience and description of technique. BJU Int. 2019. PMID: 31386793. doi:10.1111/bju.14885
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。